INGN · Inogen Inc
$5.50
-0.11 (-1.96%)
At close · Aug 24
Market Cap
$149.94M
Shares
26.54M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-07-01 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-11 | 2026-06-05 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | — | |
| 8-K | 2026-04-06 | — | |
| 8-K | 2026-03-30 | 2026-03-24 | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-02-24 | 2026-02-20 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-29 | 2025-07-24 | |
| 8-K | 2025-05-19 | 2025-05-14 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-03-27 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-02-03 | 2025-01-30 | |
| 8-K | 2025-01-27 | 2025-01-25 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-30 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-31 | 2024-07-26 | |
| 8-K | 2024-07-03 | 2024-07-02 | |
| 8-K | 2024-06-07 | 2024-06-05 | |
| 8-K | 2024-05-15 | 2024-05-10 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-18 | 2024-06-05 | |
| 8-K | 2024-04-15 | 2024-04-11 | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-24 | 2024-01-21 | |
| 8-K | 2024-01-05 | 2024-01-02 | |
| 8-K | 2023-11-27 | 2023-11-22 | |
| 8-K | 2023-11-13 | 2023-11-10 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-09-18 | 2023-09-14 | |
| 8-K | 2023-09-07 | 2023-09-01 |
Showing 1–50 of 113 filings
Key facts
CIK
1294133
CUSIP
45780L104
13F (30d)
125 filings
116 filers
Visit website
Investor relations